Chemodex

Icariin

CHF 81.00
In stock
CDX-I0172-M100100 mgCHF 81.00
More Information
Product Details
Synonyms 4'-O-Methyl-8-γ,γ-dimethylallylkaempferol-3-rhamnoside-7-glucoside; Leariline
Product Type Chemical
Properties
Formula

C33H40O15

MW 676.668
CAS 489-32-7
RTECS DJ2980500
Source/Host Chemicals Plant
Purity Chemicals ≥97% (HPLC)
Appearance Light yellow fine powder.
Solubility Soluble in DMSO (20mg/ml) or DMF (20mg/ml).
Identity Determined by 1H-NMR.
Declaration Manufactured by Chemodex.
Other Product Data

Click here for Original Manufacturer Product Datasheet
Our product description may differ slightly from the original manufacturers product datasheet.

InChi Key TZJALUIVHRYQQB-XLRXWWTNSA-N
Smiles O=C1C2=C(O)C=C(O[C@H]3[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O3)C(C/C=C(C)/C)=C2OC(C4=CC=C(OC)C=C4)=C1O[C@H]5[C@H](O)[C@H](O)[C@@H](O)[C@H](C)O5
Shipping and Handling
Shipping AMBIENT
Short Term Storage +20°C
Long Term Storage -20°C
Handling Advice Protect from light and oxygen.
Use/Stability Stable for at least 2 years after receipt when stored at -20°C.
Documents
MSDS Inquire
Product Specification Sheet
Datasheet Download PDF
Description

Icariin, the active component of the Chinese medicinal plant E. brevicornum. It has been shown to have anti-inflammatory, anticancer, antioxidant, osteoprotective, neuroprotective and cardioprotective activity. It has been shown to enhance bone formation and bone regeneration. Icariin may be beneficial to Alzheimer's disease by reducing the production of extracellular amyloid plaques and intracellular neurofibrillary tangles and inhibiting phosphodiesterase-5 activity. The anti-cancer activity is related to various mechanisms such as apoptosis and autophagy induction, cell cycle modulation, antiangiogenesis and antimetastasis, modulating multidrug resistance and immunomodulation. Icariin interacts with several pathways, like PDE, TGF-β, MAPK, PPAR, NOS, IGF, Sirtuin and others. Icariin has been shown to inhibit the NF-κ activation pathway and NLRP3 inflammasome.

Product References

(1) L.G. Ming, et al.; J. Cell Physiol. 228, 513 (2013) (Review) | (2) J.K. Schluesener & H. Schluesener; Mol. Nutr. Food Res. 58, 49 (2014) (Review) | (3) H.L. Tan, et al.; Front. Pharmacol. 7, 191 (2016 (Review) | (4) R. Shen & J.H. Wang; Am. J. Clin. Exp. Immunol. 7, 50 (2018) (Review) | (5) B. Su, et al.; Life Sci. 208, 26 (2018) | (6) J. Jin, et al.; Eur. J. Pharmacol. 842, 20 (2019) (Review) | (7) C. Angeloni, et al.; Front. Pharmacol. 10, 271 (2019) (Review) | (8) A. Yang, et al.; Stem Cells Int. 2019, 5747298 (2019) (Review)

© 2017 Adipogen Life Sciences. Pictures: © 2012 Martin Oeggerli. All Rights Reserved.